ATGE vs LRN

ATGE's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. The company demonstrates strong profitability and growth, with robust earnings surprises and high ROE, but faces headwinds from a bearish technical trend and weak liquidity ratios. Valuation is mixed: trading below analyst target of $158.25 but above the conservative Graham Number of $76.73, reflecting premium pricing for growth. Despite solid fundamentals and sector outperformance in ROE and margins, the lack of insider activity and near-term technical weakness temper bullishness.

LRN exhibits a stable financial profile with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a current ratio of 7.27. While the current price of $95.16 trades at a slight premium to the Graham Number ($72.77) and Intrinsic Value ($86.9), the valuation remains highly attractive with a PEG ratio of 0.51 and a forward P/E of 10.81. Strong profitability metrics, including an ROE of 22.26%, combined with a consistent track record of earnings beats, outweigh the current bearish technical trend. The company is fundamentally undervalued relative to its growth and efficiency.